Publications by authors named "Colin Godwin"

Claim this Profile
I
Informing the Recommended Phase III Dose of Alnuctamab, a CD3 × BCMA T-Cell Engager, Using Population Pharmacokinetics and Exposure-Response Analysis.
Brian Kiesel, Mayu Osawa, Madhan Masilamani, Merav Bar, Kevin Hsu, Colin Godwin

Clin Pharmacol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
Colin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna B Halpern, Jacob S Appelbaum

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy.
Colin D Godwin, George S Laszlo, Salvatore Fiorenza, Eliotte E Garling, Tinh-Doan Phi

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.
Colin D Godwin, Yi Zhou, Megan Othus, Mallette M Asmuth, Carole M Shaw

Blood· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia.
Colin D Godwin, Olivia M Bates, Sae Rin Jean, George S Laszlo, Eliotte E Garling

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm.
Raffaele Palmieri, Megan Othus, Anna B Halpern, Mary-Elizabeth M Percival, Colin D Godwin

J Clin Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia.
Colin D Godwin, George S Laszlo, Brent L Wood, Colin E Correnti, Olivia M Bates

Leukemia· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity.
Colin D Godwin, Olivia M Bates, Eliotte E Garling, Mary E Beddoe, George S Laszlo

Br J Haematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission.
Colin D Godwin, Jonathan R Fromm, Megan Othus, Brenda M Sandmaier, Marco B Mielcarek

Bone Marrow Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between CD33 expression, splicing polymorphism, and cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330.
George S Laszlo, Mary E Beddoe, Colin D Godwin, Olivia M Bates, Chelsea J Gudgeon

Haematologica· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.
Colin E Correnti, George S Laszlo, Willem J de van der Schueren, Colin D Godwin, Ashok Bandaranayake

Leukemia· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.
Colin D Godwin, George B McDonald, Roland B Walter

Blood· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of early death in adults with relapsed or refractory acute myeloid leukemia.
Colin D Godwin, Megan Othus, Morgan A Powell, Sarah A Buckley, Elihu H Estey

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injectable Self-Healing Glucose-Responsive Hydrogels with pH-Regulated Mechanical Properties.
Volkan Yesilyurt, Matthew J Webber, Eric A Appel, Colin Godwin, Robert Langer

Adv Mater· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.
Roland B Walter, Brenda M Sandmaier, Barry E Storer, Colin D Godwin, Sarah A Buckley

Biol Blood Marrow Transplant· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit.
Mathew J Garnett, Jörg Mansfeld, Colin Godwin, Takahiro Matsusaka, Jiahua Wu

Nat Cell Biol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis